|
| |
Ranbaxy Laboratories LimitedRanbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. It is ranked amongst the top ten generic companies worldwide. The Company has manufacturing operations in 8 countries with a ground presence in 49 countries and its products are available in over 125 countries.
Ranbaxy was incorporated in 1961 and went public in 1973. For the twelve months ended December 31, 2005, the Company's Global Sales were at US $1178 Mn. Overseas markets accounted for 76% of global sales. The Company's largest market USA with the sales of US $ 328 Mn, accounted for 28%, while Europe and BRIC (Brazil, Russia, India, China) countries contributed 17% and 29% to global sales.
| Contact Details: |
| Plot 90, Sector 32, |
| Gurgaon |
| Haryana |
| 122001 |
| India |
| Tel: | 91-124-4135000 |
| Fax: | 91-124-4135001 |
| Email: | ramesh.adige@ranbaxy.com |
| WWW: | www.ranbaxy.com/
|
| |
Recent Publications by Ranbaxy Laboratories Limited: |  |
Assessment of the putative binding conformation of a pyrazolopyridine class of inhibitors of MAPKAPK2 using computational studies.
The Ser/Thr protein kinase MAPKAP kinase2 (MAPKAPK2 or MK2) plays an... | 24th October, 2009
| Division of Molecular Modeling, New Drug Discovery Research, Ranbaxy
| Eur J Med Chem. 2009 Sep 30.
DOI Direct Link |
LC-APCI mass spectrometric method development and validation for the determination of atovaquone in human plasma.
A newly developed LC-APCI mass spectrometric method is described for human... | 28th August, 2009
| Department of Clinical Pharmacology and Pharmacokinetics, Ranbaxy
| Biomed Chromatogr. 2009 Aug 25.
DOI Direct Link |
Dictyostelium discoideum--a promising expression system for the production of eukaryotic proteins.
In general, four different expression systems, namely, bacterial, yeast,... | 1st January, 2009
| Department of Biotechnology and Bioinformatics, Ranbaxy Laboratories
| FASEB J. 2008 Dec;22(12):4055-66. Epub 2008 Aug 19.
DOI Direct Link |
The effect of water activity and storage temperature on the growth of Aspergillus flavus in medicinal herbs.
The quality control of medicinal herbs post harvesting or after collection... | 29th October, 2008
| Ranbaxy Laboratories Limited, Gurgaon, (Haryana), India.
| Planta Med. 2008 Aug;74(10):1308-15. Epub 2008 Jun 13.
DOI Direct Link |
Molecular targeting of E3 ligases--a therapeutic approach for cancer.
BACKGROUND: The ubiquitin-proteasomal degradation pathway plays a critical... | 30th August, 2008
| Ranbaxy Laboratories Ltd, New Drug Discovery Research, R&D-III, Sector-18,
| Expert Opin Ther Targets. 2008 Jul;12(7):855-70.
DOI Direct Link |
→View more Ranbaxy Laboratories Limited research publications. |
Press Releases on Ranbaxy Laboratories Limited:
|
 |
| Reportlinker Adds Asia Pacific Pharma Sector Analysis |
12th November, 2009 |
Reportlinker |
NEW YORK, Nov. 12 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Asia Pacific Pharma Sector Analysis
http://www.reportlinker.com/p0163724
|
| Nuvo research provides WF10 licensing and development update |
11th November, 2009 |
Nuvo Research Inc. |
MISSISSAUGA, ON, Nov. 11 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to and
|
| Reportlinker Adds World Market for Biosimilars and the Potential for US Follow-on Biologics, The Report |
24th September, 2009 |
Reportlinker |
-- Current market size and forecasts for biogenerics in Europe and Rest of
World Markets
-- Review of Marketed Biological Drugs with Expired Patents
-- Review of
|
| Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets |
5th March, 2009 |
Ranbaxy Pharmaceuticals Inc. |
PRINCETON, N.J., March 5 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U
|
| Press Statement Issued by Ranbaxy Laboratories Limited |
25th February, 2009 |
Ranbaxy Laboratories Limited |
GURGAON, India, Feb. 25 /PRNewswire/ -- Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxy's Paonta Sahib facility have been added to a
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1458 times since April 2007, the link to the organisation's website has been followed 207 times Recent Search Terms used to find this page: Branches Of Ranbaxy In india | ranbaxy india omega 3 capsules | Ranbaxy branches in INDIA | Ranbaxy Laboratories Ltd branches | omega 3 ranbaxy | r d branch of ranbaxy farmaceutical company | ranbaxy omega 3 | location of branches of Ranbaxy in india | location of branches of Ranbaxy in india | omega 3 capsule ranbaxy | . Search for more companies in Gurgaon Search for more companies in Haryana This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Ranbaxy Laboratories Limited |
